Salvatore U. Berlangieri

Author

Also Known As

S BERLANGIERI, S Berlangieri, S U BERLANGIERI, S U Berlangieri, S. Berlangieri, S. U. BERLANGIERI, S. U. Berlangieri, S.U. Berlangieri, SALVATORE BERLANGIERI, SALVATORE U. BERLANGIERI

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Melbourne Ludwig Cancer Research Austin Hospital Austin Health Heidelberg Repatriation Hospital

About

Salvatore U. Berlangieri is an author at The University of Melbourne specializing in radiology, medicine, and positron emission tomography.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.2K
2	Health Sciences	9	9	465
3	Engineering	4	4	757
4	Public Health	1	1	38
5	Social Sciences	1	1	55

Salvatore U. Berlangieri

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism Christopher C. Rowe, Uwe Ackerman, William F. Browne, The Lancet Neurology Positron Emission TomographyAmyloid βNeurodegenerative DiseasesNeuroimaging BiomarkersAlzheimer's Disease	2008	664
Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease Siew Hiang Sally Ng, VL Villemagne, Salvatore U. Berlangieri, Journal of Nuclear Medicine	2007	257
CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMA Shakher Ramdave, G. Thomas, Salvatore U. Berlangieri, The Journal of Urology	2001	201
The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1Presented at the 13th Asia Pacific Cancer Conference, Penang, Malaysia, November 17–20, 1996 and also presented at the Royal Australasian College of Radiologists 47th Annual General and Scientific Meeting, Perth, Western Australia, October 5–9th, 1996. Accepted for presentation at the American Radium Society 79th Annual Meeting, New York, N.Y., April 30–May 4, 1997.1 John D Kiffer, Salvatore U. Berlangieri, Andrew M. Scott, Lung Cancer Oncologic ImagingNew YorkPositron Emission TomographyRadiation MedicineWestern Australia	1998	189
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. Lawrence Cher, Carmel Murone, Nathan Lawrentschuk, PubMed	2006	178
Evaluation of 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Histopathologic Correlation in the Initial Staging of Head and Neck Cancer Anthony Hannah, Andrew M. Scott, Henri Tochon‐Danguy, Annals of Surgery	2002	175
Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy S. Ho, Samuel F. Berkovic, Salvatore U. Berlangieri, Annals of Neurology	1995	154
Hippocampal Atrophy Is Not a Major Determinant of Regional Hypometabolism in Temporal Lobe Epilepsy Terence J. O’Brien, M. R. Newton, Mark Cook, Epilepsia	1997	109
Autosomal dominant nocturnal frontal lobe epilepsy: Demonstration of focal frontal onset and intrafamilial variation Michael J. Hayman, Ingrid E. Scheffer, Yotin Chinvarun, Neurology Intrafamilial VariationSeizure LocalizationNeurophysiological BiomarkersNeuropsychiatryBrain Lesion	1997	93
Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy Salvatore U. Berlangieri, David M. Brizel, Richard L. Scher, Head & Neck	1994	65

Page 1